.Atea Pharmaceuticals' antiviral has fallen short yet another COVID-19 trial, but the biotech still ...
.Neurocrine Biosciences' schizophrenia system pivot has neglected. The biotech was actually unable t...
.Sanofi has created a late entry to the radioligand event, spending one hundred thousand europeans (...
.After F2G's first effort to receive a new course of antifungal to market was actually derailed due ...
.Moderna has pledged to cut R&D costs through $1.1 billion by 2027. The choice to retract the bud...
.Just four months after Sanofi wager $80 million in ahead of time money on Fulcrum Therapies' losmap...
.Cancer cells firm Oncternal Therapies is actually folding all its own medical tests and also giving...
.Roche is actually storing out hopes that its injectable weight problems possibility can eventually ...
.Novo Nordisk has lifted the lid on a stage 1 trial of its oral amylin and GLP-1 receptor co-agonist...
.Just a few quick weeks after succeeding an FDA Fast Track tag for its investigational BTK degrader ...